Aurora, CONCT04184973Now EnrollingIRB Ready

Rectal Cancer Clinical Trial in Aurora, CO

Access cutting-edge rectal cancer treatment through this clinical trial at a research site in Aurora. Study-provided care at no cost to qualified participants.

Sponsored by Colospan Ltd.

Quick Self-Assessment

See if you qualify for this Aurora location

Preparing your pre-screening questions…

Expert Care in Aurora

Access rectal cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related rectal cancer treatment provided free

Apply for This Aurora Location

Check if you qualify for this rectal cancer clinical trial in Aurora, CO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Aurora

    Convenient for CO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Aurora site if eligible
  4. 4Begin participation

About This Rectal Cancer Study in Aurora

A randomized trial to assess the safety and efficacy of CG-100 for reducing stoma creation rate in subjects undergoing mesorectal excision.

Sponsor: Colospan Ltd.

Who Can Participate

Inclusion Criteria

The patient is willing to comply with protocol-specified follow-up evaluations
Patient 22-65 years of age at screening, or patient 66-70 years of age at screening with up to one cardiovascular, metabolic or pulmonary comorbidity for which medication is prescribed.
Patient is diagnosed with colorectal cancer
Patient is scheduled for elective either open, laparoscopic or robotic with mesorectal excision (either abdominal or transanal approach) which will require the creation of an anastomosis, maximally 10 cm from the anal verge
Patients who are scheduled to receive a protective stoma under routine clinical practice during their primary planned operation.
Patient is scheduled to undergo mechanical bowel preparation
The patient has been informed of the nature of the study, agrees to its provisions and has provided written informed consent, approved by the appropriate Medical Ethics Committee (EC) or Institutional Review Board (IRB).

Exclusion Criteria

Patient has local or systemic infection at the time of intervention (e.g., peritonitis)
Major surgical or interventional procedures within 45 days prior to this study or planned surgical or interventional procedures within 6 months of entry into this study (not including, placement of port for chemotherapy or ureter stent insertion).
Patients with ASA classification \> 3
Albumin \< 30 g/liter
Patient has a diagnosis of bowel obstruction, bowel strangulation, peritonitis, bowel perforation, ischemic bowel, carcinomatosis or extensively spread inflammatory bowel disease
Patients has a diagnosis of coagulopathy, thrombocytopenia, immune suppression
Patient is going through another surgical procedure (other than ileostomy, adhesiolysis) during the surgery.
The patient is currently participating in another investigational drug or device study unless pre-approved by the sponsor.
Patient has been taking regular systemic/ steroid medication in the last 6 months.
Patients is taking antimetabolites or antiplatelet agents.
Patient has preexisting sphincter problems
Patient has evidence of extensive local disease in the pelvis or has undergone a prior pelvic anastomosis.
Patients with massive diverticulosis at the sigmoid/descending colon (viewed on preoperative CT)
Any condition or abnormality which in the opinion of the investigator may jeopardize the patient's safe participation or the quality of the data
Pregnant or nursing female patients. Female patients of child-bearing potential must have a negative pregnancy test done within 7 days prior to surgical procedure per site standard test.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Aurora?

Yes, this clinical trial (NCT04184973) has an active research site in Aurora, CO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Rectal Cancer Treatment Options in Aurora, CO

If you're searching for rectal cancer treatment options in Aurora, CO, this clinical trial (NCT04184973) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Aurora research site is actively enrolling participants for this clinical trial. You'll receive care from experienced rectal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all rectal cancer clinical trials near you to find additional studies recruiting in your area.

More Colorectal Cancer Trials in Aurora, CO

See all colorectal cancer clinical trials recruiting in Aurora — not just this study.

Browse Colorectal Cancer Trials in Aurora

Browse More Trials by Condition

Ready to Join in Aurora?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Aurora, CO